Matthew K Harbaugh
CIK 1578368 · Chief Financial Officer · last filed 2025-12-05
Matthew K Harbaugh is a Chief Financial Officer who has filed 41 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for Q, was dated Dec 5, 2025. Across all open-market trades the lifetime net is −$2.6M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
41
-$2.65M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Q | Chief Financial Officer | — | $150.65 | — | $0 | 1 | 2025-12-05 |
| NUVASIVE INC (NUVA) Delisted | EVP and CFO | 0 | $39.75 | $0 | $0 | 7 | 2023-09-05 |
| Keenova Therapeutics plc (MNK) Delisted | EVP & President, Spec Gen | 104,115 | $0.34 | $35.4K | -$2.65M | 32 | 2019-04-03 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-05 | Q | Grant (A) | — | $0 | EDGAR |
| 2025-11-04 | — | Other (J) | +9,291 | $0 | |
| 2023-09-05 | NUVASIVE INC (NUVA) Delisted | Disp (D) | −11,081 | $0 | EDGAR |
| 2023-03-03 | NUVASIVE INC (NUVA) Delisted | Mixed | +8,664 | -$150.5K | EDGAR |
| 2023-01-03 | NUVASIVE INC (NUVA) Delisted | Mixed | +846 | -$18.1K | EDGAR |
| 2022-03-03 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-03 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-03 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-03 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −2,533 | -$57.8K | EDGAR |